CervoMed Inc.

CRVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $8.2M $9.0M $7.8M $4.1M $37.3M $18.5M $14.2M $8.0M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $22.9M $43.1M $10.0M $4.2M $37.8M $18.8M $14.6M $8.9M
Property, Plant & Equipment — — — — $0 $149.2K $252.4K $350.3K
Goodwill — — — — — — — $0
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $22.9M $43.1M $10.0M $4.2M $37.8M $27.7M $24.1M $18.2M
Liabilities
Accounts Payable $1.5M $1.5M $662.5K $97.3K $947.5K $545.8K $1.3M $198.8K
Total Current Liabilities $4.7M $3.9M — — $2.9M $2.4M $1.7M $804.0K
Long-Term Debt — — — — — — — —
Total Liabilities $4.7M $3.9M $2.6M $13.2M $2.9M $2.9M $4.0M $2.6M
Stockholders' Equity
Retained Earnings $-97.7M $-70.7M $-54.4M $-52.3M $-130.0M $-105.9M $-91.7M $-79.9M
Total Stockholders' Equity $18.2M $39.2M $7.4M $-33.3M $34.9M $24.8M $20.1M $15.6M
← Newer Page 1 of 2 Older →